National Quality Evaluation of Medication Use for Pediatric Otitis Media With Effusion

Yu-Lu Chen1, Te-Yung Fang2,3, Pa-Chun Wang2,3,4

  • 1Department of Pharmacy, Cathay General Hospital, Taipei.

Insights

Medication use for pediatric otitis media with effusion (OME) often deviates from clinical guidelines. Factors like age and comorbidities increase drug prescriptions, highlighting the need for updated treatment guidelines in Taiwan.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Public Health

Background:

  • Otitis media with effusion (OME) affects up to 60% of children under two.
  • OME involves middle ear fluid without acute infection signs.
  • Ventilation tube insertion (VTI) is a common treatment for persistent OME.

Purpose of the Study:

  • To investigate medication use in pediatric OME patients before VTI.
  • To assess adherence to clinical practice guidelines for OME medication.
  • To identify factors influencing medication choices in OME treatment.

Main Methods:

  • Retrieved data from Taiwan's National Health Insurance Research Database (NHIRD).
  • Analyzed medication use (antibiotics, antihistamines, steroids) in pediatric OME patients (≤12 years) from 2011-2012.
  • Examined associations between patient/provider factors and medication prescription patterns.

Main Results:

  • Systemic antibiotics were most frequently used (59.9%), followed by antihistamines (23.4%), intranasal steroids (9.6%), and systemic steroids (8.8%).
  • Twelve factors influenced antibiotic use; age (>2 years), comorbidities, and hospital type were associated with increased use.
  • Catastrophic illness and watchful waiting were linked to decreased antibiotic use.

Conclusions:

  • Current medication use for pediatric OME in Taiwan does not align with clinical practice guidelines.
  • Increased influencing factors correlated with higher rates of drug utilization.
  • Developing台湾-specific OME treatment guidelines is recommended to align practice with evidence.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
57
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
49
Nursing Evaluation01:15

Nursing Evaluation

The evaluation stage signals the end of the nursing process. The nurse gathers evaluative data to assess whether or not the patient has attained the expected results. Whereas the nurse collects data in the nursing assessment to identify the patient's health concerns, the evaluation stage data determines if the indicated health issues are resolved. Evaluative data collection includes two sections: the data acquired to evaluate patient outcomes and the time criteria for data collection.
3.8K
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
49
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
71